"Key-Whitman Eye Center proudly serves patients throughout the Dallas Fort Worth Metroplex and have been a staple in the local community since 1961. This advanced experience and knowledge allows them to provide a higher standard of care across a broad range of eyecare services, including LASIK (for which they offer free consultations), cataract surgery, and many cosmetic services. They also accept most insurance policies and Medicare. Serving patients in English, Spanish, and Mandarin, they hold themselves to a higher standard of care and prioritize great patient services in everything they do. To learn more, schedule your appointment with Key-Whitman Eye Center today!"

During the past decade, Key-Whitman Eye Center conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 10 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 8 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Key-Whitman Eye Center" #1 sponsor was "Johnson & Johnson Surgical Vision, Inc." with 4 trials, followed by "ReVision Optics, Inc." with 3 trials sponsored, "Staar Surgical Company" with 3 trials sponsored, "Refocus Group, Inc." with 2 trials sponsored and "Abbott Medical Optics" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

According to Clinical.Site data, the most researched conditions in "Key-Whitman Eye Center" are "Cataract" (7 trials), "Presbyopia" (7 trials), "Myopic Astigmatism" (3 trials), "Corneal Astigmatism" (2 trials) and "Myopia" (2 trials). Many other conditions were trialed in "Key-Whitman Eye Center" in a lesser frequency.

Most popular intervention types in "Key-Whitman Eye Center" are "Device" (15 trials), "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Raindrop Near Vision Inlay" (3 trials), "Control IOL" (1 trials), "Control Monofocal Intraocular Lens: TECNIS Monofocal IOL" (1 trials), "EVO ICL" (1 trials) and "EVO/EVO+ Visian ICL" (1 trials). Other intervention names were less common.

The vast majority of trials in "Key-Whitman Eye Center" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Key-Whitman Eye Center". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 9 completed trials in Key-Whitman Eye Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Key-Whitman Eye Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 13 trials that are defined as “Not Applicable".